Department Of Health And Human Services
New Animal Drugs; Change of Sponsor; Change of Sponsor Address; Lincomycin and Spectinomycin Soluble Powder; Sulfadimethoxine Oral Solution and Soluble Powder; Tiamulin
September 14, 2012 - 77 FR 56769 - RIN: - Download Full Notice: Text | PDF
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for three abbreviated new animal drug applications (ANADAs) from Teva Animal Health, Inc., to Phibro Animal Health Corp. FDA is also amending the regulations to reflect a change of sponsor's address for Phibro Animal Health Corp. and for Eka Chemicals, Inc.
Agency Contact: Steven D. Vaughn, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7520 Standish Pl., Rockville, MD 20855, 240-276-8300, email: steven.vaughn@fda.hhs.gov.
This rule is final. Its effective date is September 14, 2012.
Related Links
Submit links with information related to this regulation and your link will appear right here on this page. Agency docs, academic and industry reports, news articles are all appropriate.
How Can We Improve?
We want to make OpenRegs.com as useful tool for everyone interested in regulation. Please help us improve by sending us your comments and suggestions.
OpenRegs.com is an easy-to-navigate regulatory portal. Every day, federal agencies issue dozens of rules that affect you, your business, and your family. We make it easy to keep track of proposed and final regulations and to submit comments to the agencies, so that citizens can become better informed and more involved in the regulatory process.
